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Abstract
 
Mice deficient in lymphotoxin 
 
b
 
 receptor (LT
 
b
 
R) or interleukin 7 receptor 
 
a
 
 (IL-7R
 
a
 
) lack
Peyer’s patches (PPs). Deficiency in CXC chemokine receptor 5 (CXCR5) also severely affects
the development of PPs. A molecular network involving these three signaling pathways has
been implicated in PP organogenesis, but it remains unclear how they are connected during
this process. We have shown that PP organogenesis is initiated at sites containing IL-7R
 
a
 
1
 
lymphoid cells and vascular cell adhesion molecule (VCAM)-1/intercellular adhesion molecule
(ICAM)-1 expressing nonlymphoid elements. Here we characterize these lymphoid and non-
lymphoid components in terms of chemokine signals. The lymphoid population expresses
CXCR5 and has a strong chemotactic response to B lymphocyte chemoattractant (BLC). Im-
portantly, chemokines produced by VCAM-1
 
1
 
ICAM-1
 
1
 
 nonlymphoid cells mediate the re-
cruitment of lymphoid cells. Furthermore, we show that these VCAM-1
 
1
 
ICAM-1
 
1
 
 cells are
mesenchymal cells that are activated by lymphoid cells through the LT
 
b
 
R to express adhesion
molecules and chemokines. Thus, promotion of PP development relies on mutual interaction
between mesenchymal and lymphoid cells.
Key words: lymphoid tissue • lymphotoxin • interleukin 7 • chemokines • chemotaxis
 
Introduction
 
Secondary lymphoid tissues including the spleen (Spl),
 
1
 
LNs, and Peyer’s patches (PPs) are thought to serve as focal
regions that mediate and facilitate the cell–cell interactions
required for Ab formation. To understand how the highly
organized structures of these organs are formed, it is impor-
tant to identify the cellular components and intercellular
signals that comprise the initial phase of organogenesis.
Molecular and genetic analyses have revealed a complex
network of molecules involved in lymphoid organogenesis
(1, 2). As for PP organogenesis, one group of important sig-
naling molecules are TNF family molecules. Mice deficient
in lymphotoxin (LT)
 
a
 
/
 
b
 
 heterotrimer and its receptor
LT
 
b
 
R fail to develop organized PPs (3, 4, 5). Moreover,
the role of LT
 
a
 
 homotrimer and its receptor TNFRp55
was also implicated (6). Another group is IL-7R, members
of the cytokine receptor family. Mice lacking expression of
IL-7R
 
a
 
, 
 
g
 
c, and their downstream target, Janus kinase
(JAK)3, were defective in PP development (7, 8). Interest-
ingly, these two groups of molecules are required within a
narrow time window during the development of PPs (9,
10). B lymphocyte chemoattractant (BLC) and its receptor,
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CXC chemokine receptor 5 (CXCR5), have also been
shown to be required for PP organogenesis, as the disrup-
tion of these genes resulted in abnormal PP development
(11, 12).
It is likely that LT influences lymphoid organogenesis
through the induction of adhesion molecules and chemo-
kines. It was shown that the LT
 
a
 
 homotrimer can act on
endothelial cells to induce vascular cell adhesion molecule
(VCAM)-1 and intercellular adhesion molecule (ICAM)-1
(13). Although unable to stimulate endothelial cells, the
LT
 
a
 
/
 
b
 
 heterotrimer can induce adhesion molecules on
nonendothelial stromal cell components (14, 15). Further-
more, a recent study has established a critical role for
TNFRp55 and LT
 
b
 
R signaling in regulating the expres-
sion of homeostatic chemokines such as BLC, EBV-
induced molecule (EBI)-1 ligand chemokine (ELC), and
secondary lymphoid organ chemokine (SLC) in secondary
lymphoid organs (16). Although these studies have greatly
enhanced our knowledge on the signaling networks in-
volved in PP organogenesis, the cellular interactions under-
lying the network remain largely obscure. Interestingly, B
lymphocytes have been demonstrated as an indispensable
source of LT
 
a
 
/
 
b
 
 heterotrimers (11, 17, 18). In a study on a
transgenic model expressing BLC, lymphoid neogenesis
was observed in a B cell–dependent manner (19). How-
ever, as PP development remained intact in the absence of
T and B lymphocytes (20), it must be assumed that cells
other than mature lymphocytes are receiving or producing
organogenic signals.
We have previously reported that developing PPs can
first be detected at around gestational day 16 as clusters of
VCAM-1
 
1
 
ICAM-1
 
1
 
 (V
 
1
 
I
 
1
 
) mesenchymal-like cells and
CD3
 
2
 
IL-7R
 
a
 
1
 
 lymphoid cells (20). As the CD3
 
2
 
IL-
7R
 
a
 
1
 
 population in the embryonic gut is capable of ex-
pressing LT
 
a
 
/
 
b
 
 and both IL-7R
 
a
 
 and LT
 
a
 
/
 
b
 
 are essential
for PP organogenesis, it is likely that this population repre-
sents a PP inducer (10). We further hypothesized that
LT
 
a
 
/
 
b
 
 expressed in PP inducers activate surrounding non-
lymphoid cells which function as a PP organizer to regulate
subsequent processes such as recruitment of various he-
matopoietic cells to the PP anlage (21, 22). Additional sup-
port for this proposed mechanism was obtained from a
study of helix-loop-helix inhibitor Id2
 
2
 
/
 
2
 
 mice (23). In
Id2
 
2
 
/
 
2
 
 mice, both the differentiation of CD4
 
1
 
CD3
 
2
 
IL-
7R
 
a
 
1
 
 cells and the formation of V
 
1
 
I
 
1
 
 cell clusters are in-
hibited. This notion fits well with the hypothesis that
CD4
 
1
 
CD3
 
2
 
 cells play a role in LN organogenesis (24).
In this study, to further promote our understanding of
molecular and cellular events involved in the initial phase
of PP development, we isolated and characterized
CD4
 
1
 
CD3
 
2
 
IL-7R
 
a
 
1
 
 lymphoid and V
 
1
 
I
 
1
 
 nonlymphoid
populations using cell-surface markers and flow cytometry.
We show that migration and activation of CD4
 
1
 
CD3
 
2
 
IL-
7R
 
a
 
1
 
 cells are regulated by V
 
1
 
I
 
1
 
 cells. We find that these
V
 
1
 
I
 
1
 
 cells are mesenchymal and in turn are activated by
CD4
 
1
 
CD3
 
2
 
IL-7R
 
a
 
1
 
 cells through LT
 
b
 
R to express
VCAM-1, ICAM-1, BLC, and ELC. Our results indicate
that mutual activation of lymphoid and mesenchymal cells
 
occurs in PP anlagen, and that these interactions are the
underlying mechanisms of PP organogenesis.
 
Materials and Methods
 
Mice.
 
C57BL/6 and LT
 
a
 
2
 
/
 
2
 
 mice were purchased from Ja-
pan SLC, Inc. and The Jackson Laboratory, respectively. Estab-
lishment of Id2
 
2
 
/
 
2
 
 and IL-7R
 
a
 
2
 
/
 
2
 
 mice was reported previously
(23, 25). Matings were conducted overnight, and noon of the day
vaginal plugs were observed was designated as embryonic day
(E)0.5. All animal procedures described in this study were per-
formed in accordance with the guidelines for animal experiments
of Kyoto University Graduate School of Medicine.
 
Construction of Fusion Proteins.
 
An expression construct en-
coding a fusion of the extracellular domain of murine LT
 
b
 
R
(amino acids 1–222) and Fc portion of human IgG
 
1
 
 (LT
 
b
 
R-Ig)
was made by PCR amplification of the former with CGGAAT-
TCTGGTCAGCCGAGCCGAAAGG and CGGGATCCAT-
TGCTCCTGGCTCTGGGGG as 5
 
9
 
 and 3
 
9
 
 primers, respec-
tively. The PCR product was subcloned into the EcoRI and
BamHI sites of a pBSK vector containing the Fc portion of hu-
man IgG1 (provided by B. Seed, Harvard Medical School, Bos-
ton, MA) and the resulting LT
 
b
 
R-Ig fragment was transferred
into a mammalian expression vector pMKITneo (provided by K.
Maruyama, Tokyo Medical Dental University, Tokyo, Japan).
COS-7 cells were transfected with pMKITneo/LT
 
b
 
R-Ig by li-
pofection and fusion proteins were purified using protein-G
Sepharose columns (Amersham Pharmacia Biotech). A fusion
protein consisting of the extracellular domain of mTNFRp55
(amino acids 1–212; TNFRp55-Ig) was prepared similarly with
TCAGAATTCCGGACATGGGTCTCCCCACC and TCAG-
GATCCGCAGTACCTGAGTCCTGGGG as primers. Hu-
man-IgG Fc fragment (ChromPure™; Jackson ImmunoResearch
Laboratories) was used as a control.
 
Abs.
 
Anti–VCAM-1 mAb (RAV2; a gift from T. Kina, Ky-
oto University) was labeled with Alexa™ 488 or Alexa™ 594
(Molecular Probes, Inc.). PE- and FITC-conjugated anti–ICAM-1
mAb (3E2), FITC- or biotin-conjugated anti-CD4 mAb (RM4-5),
and PE-conjugated anti-CD3e mAb (2C11) were purchased
from BD PharMingen. Biotin conjugated Abs for mucosal ad-
dressin cell adhesion molecule (MAdCAM)-1 (MECA-89),
CD45 (30-F11), CD40 (3/23), B220 (RA3-6B2), CD35 (8C12),
CD23 (B3B4), CD11c (HL3), CD11b (M1/70), and PECAM-1
(MEC13.3) were purchased from BD PharMingen. mAbs for
VE-cadherin (VECD-1), platelet-derived growth factor receptor
(PDGFR)-
 
a
 
 (APA-5), PDGFR-
 
b
 
 (APB-5), Flk-1 (AVAS12),
and IL-7R
 
a
 
 (A7R34; reference 26) were prepared and labeled in
our laboratory. Anti-LT
 
b
 
R mAb (AFH6; reference 27), anti–
BP-3 mAb (a gift of M.D. Cooper, Howard Hughes Medical In-
stitute, University of Alabama, Birmingham, Alabama), and anti-
FDC–M1 mAb (a gift of G. Kelsoe, Duke University Medical
Center, Durham, NC) were biotinylated in our laboratory.
For blocking IL-7R
 
a
 
 in vivo, 3 mg of A7R34 was injected in-
traperitoneally into pregnant mice. Polyclonal rat IgG (Sigma-
Aldrich) was injected as a control.
 
Isolation of CD4
 
1
 
CD3
 
2
 
IL-7R
 
a
 
1
 
 Cells and V
 
1
 
I
 
1
 
 Cells from Em-
bryonic Intestine. For preparation of CD41CD32IL-7Ra1 cells,
embryonic small intestines freed from mesenteries were treated
with 2 U/ml of dispase (GIBCO BRL) at 378C for 15 min,
shaken vigorously manually, and washed with ice-cold HBSS/
1% BSA.
For preparation of V1I1 cells, minced embryonic small intes-
tines were digested at 378C for 1 h with 100 U/ml each of colla-623 Honda et al.
genase types I and IV (GIBCO BRL) in HBSS containing 2.5
mM CaCl2, 10 mM Hepes, pH 7.5, and DNase I (50 mg/ml;
Sigma-Aldrich) and then incubated in dissociation buffer
(GIBCO BRL) in a shaking water bath for 15 min. Cell suspen-
sions were passed through glass wool column to eliminate the ep-
ithelial cells (28).
Cell suspensions were incubated in mouse sera to block non-
specific Ab binding and stained with labeled mAbs. For isolation
of gated cells by a FACS Vantage™ (Becton Dickinson), enrich
mode followed by normal-R mode sorting was performed while
being gated to exclude small debris, propidium iodide (Sigma-
Aldrich)-positive dying cells, and other sources of background in-
terference. Isolated cells were obtained at a purity of .98%. In
some experiments, CD41 cell isolation from embryonic intestines
was performed with Dynabeads Mouse CD4 (L3T4) and DE-
TACHaBEAD Mouse CD4 (Dynal) according to the manufac-
turer’s protocol. Until E17.5, all of the CD41 cells in the intes-
tine were CD32IL-7Ra1. Purity of the isolated cells was .90%.
The yield of V1I1 cells and CD41 cells from each mouse embry-
onic small intestine was around 5 3 102 and 5 3 103, respec-
tively.
Flow Cytometry Analysis. Three-color analyses of V1I1 cells
were performed with Alexa™ 488–conjugated anti–VCAM-1,
PE-conjugated anti–ICAM-1, and biotinylated mAbs followed
by allophycocyanin-conjugated streptavidin (Molecular Probes,
Inc.). Biotin-conjugated isotype-matched mAbs (BD PharMin-
gen) were used as controls. After staining, fluorescence intensity
was measured on samples of 106 cells by FACS Vantage™ (Bec-
ton Dickinson).
In the analysis with LTbR-Ig, CD41 cells were cultured in
various concentrations of murine rIL-7 (a gift from T. Sudo,
Toray Basic Research Laboratories, Kanagawa, Japan) in RPMI
1640/5% FCS for 6 h. Cells were suspended in HBSS/2% mouse
serum/rat anti–mouse CD32/16 mAb (2.4G2; BD PharMingen)
to block Fc receptor binding, stained with LTbR-Ig, and fol-
lowed by detection with PE-labeled donkey anti–human IgG
(Jackson ImmunoResearch Laboratories).
Immunohistochemistry. Whole-mount immunohistostaining
was performed as described previously (20). In brief, specimens
were fixed 1 h in 2% paraformaldehyde (pH 7.4) on ice, washed
with PBS, serially dehydrated with methanol, blocked for intrin-
sic peroxidase activities in 0.3% of H2O2, and rehydrated. After
incubation with PBSMT (1% skim milk, 0.3% Triton X-100 in
PBS) to block nonspecific bindings, specimens were incubated in
primary Abs overnight, and washed in PBST (0.3% Triton X-100
in PBS). After incubation with horseradish peroxidase (HRP)-
conjugated secondary reagents, color reactions were carried out
with diaminobenzidine and nickel chloride.
For immunofluorescence microscopy, fetal intestines were em-
bedded in OCT compound, snap frozen in liquid nitrogen, and
stored at 2808C. Cryostat sections (10-mm thick) were dried and
fixed with acetone. Slides were preincubated for 30 min in PBS/
0.05% Tween 20/2% BSA/2% heat-inactivated goat serum be-
fore incubation with conjugated Abs in a humidified chamber for
1 h at room temperature. After three washes in PBS, confocal mi-
croscopy was performed using a Leica TCS-NT laser scanning
microscope and Leica image software.
RNA Expression Studies. For Northern analysis, 5 mg of
poly(A)1 RNA of fetal mouse intestine was separated by electro-
phoresis in a 1.0% agarose-formaldehyde gel and transferred onto
filters. Radioactive DNA probes for BLC and ELC were pre-
pared by random-primed labeling of a 527-bp cDNA fragment of
mouse BLC (nucleotides 9–535) and a 693-bp cDNA fragment of
mouse ELC (nucleotides 16–708). The blot was hybridized with
a probe, and visualized by the BAS 5000 system (Fuji Film and
Photo, Inc.). Full-length glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) cDNA was used as a control for quantitating
amount loaded.
Whole-mount in situ hybridization was conducted as de-
scribed previously (29). Fetal small intestines were isolated and
fixed in cold 4% paraformaldehyde/PBS overnight. After wash-
ing, the intestines were treated with 100 mg/ml proteinase K
(Sigma-Aldrich), and hybridized with digoxigenin-labeled RNA
probes. After hybridization, samples were treated with RNase A
(Sigma-Aldrich), incubated with alkaline phosphatase–conjugated
antidigoxigenin Ab (Boehringer) at 48C overnight, and devel-
oped with a reaction mixture for alkaline phosphatase containing
polyvinyl alcohol.
Reverse Transcription PCR Analyses. Total RNA was isolated
from sorted cells using ISOGEN (Nippon gene). First-strand
cDNA was produced from 300 ng total RNA by reverse tran-
scription (RT) using oligo-dT primers (SuperScript Preamplifica-
tion System; GIBCO BRL) following the manufacturer’s proto-
cols. PCR amplifications were performed with specific primers
for CD4, IL-7Ra, CD3e, CXCR5, CC chemokine receptor
(CCR)7, ELC, and BLC. GAPDH signals were used to calibrate
differences in the amount of starting cDNA between samples.
Specific primers were as follows: CD4/S, ACTGCATCAG-
GAAGTGAACCTTG; CD4/AS, TCTCACTGAGGAGC-
CTCTTGAT; CD3e/S, AGATTGTCTGCCAGCCACCTTG;
CD3e/AS, GGACCTGTGCCAATGATTACAG; IL-7Ra/S,
GTCCATTATCCAAACTGAGTCG; IL-7Ra/AS, CATCG-
GAGGACTCCATTCACTG; CCR7/S, AGAATACCACG-
GTGGACTACA; CCR7/AS, GCAGCTGCTATTGGTGAT-
GTT; CXCR5/S, ATGAACTACCCACTAACCCTG; CXCR5/
AS, AGGTGAACCAGGCTCTAGTTT; ELC/S, CTGCCT-
CAGATTATCTGCCAT; ELC/AS, GCCAGAGTGATT-
CACATCTCT; BLC/S, TGAGGCTCAGCACAGCAACG;
BLC/AS, CTTGAGCATTCCCTCTCAGCT; GAPDH/S,
ATGGTGAAGGTCGGTGTGAACGGATTTGGC; and
GAPDH/AS, GCATCGAAGGTGGAAGAGTGGGAGTT-
GCTG.
In Vitro Chemotaxis. Isolation of B cells from Spl was per-
formed following the essentially same procedure as described pre-
viously (30), except that anti-CD43 mAb (BD PharMingen)
coated anti–rat IgG Dynabeads (Dynal) were used. Flow cytome-
try analysis confirmed that the purity of isolated B cells was
.94% CD191 cells. Chemotaxis assays were performed in poly-
carbonate membrane, 6.5-mm diameter, 5-mm pore size Trans-
well cell culture chambers (Corning Costar Corp.). 100 ml ali-
quots of cells (2 3 104/ml) suspended in RPMI/2% FCS were
added to the upper chambers and chemokines were added to the
lower wells. The cells were allowed to migrate for 2 h at 378C in
a 5% CO2 incubator, after which the number of cells that mi-
grated to the lower chamber were counted by flow cytometry.
Murine ELC and SLC were obtained from R&D Systems and
murine BLC from Dako.
Electron Microscopy. FACS® sorted cells were fixed immedi-
ately with 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH
7.4) for 1 h at room temperature. Cells were then washed and
postfixed in 1% osmium tetroxide for 1 h at 48C. After further
washing, cells were dehydrated in a graded series of alcohol and
embedded in Epon812. Ultrathin sections (90–150 nm) were cut
on a microtome (LKB 8000 Ultratome) and routinely stained
with uranylacetate and lead citrate for examination with a 200
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Results
Chemokine Reactivity of PP Inducers. We previously re-
ported that embryonic intestinal CD32IL-7Ra1 cells pro-
duce LTa/b and play an essential role in PP organogenesis
(10) and adopted the term “PP inducer” to designate this
population. Approximately half of these PP inducer cells
also express CD4, which has been implicated as a marker
for the population involved in the induction of mesenteric
LN (24). Although it is still unclear whether only CD41
cells or both CD41 and CD42 cells are PP inducers, this
study focuses on the CD41 population to allow compari-
son with the study by Mebius et al. (24).
At E16.5, CD41 cells begin to form segregated clusters
in embryonic intestine, in contrast to the scattered pattern
over the gut that is observed up to E15.5. By E17.5, in-
creasing numbers of CD41 cells are recruited to PP anlagen
(Fig. 1 A). We attempted to investigate the molecular
mechanisms underlying this clustering process. If the mi-
gration of CD41 cells is regulated by specific chemokines,
the corresponding chemokine receptors should be ex-
pressed in the PP inducers. Among the characterized re-
ceptors, CXCR5 and CCR7 have been suggested to par-
ticipate in the accumulation of PP inducers. In particular,
CXCR5 was a likely candidate, because mice genetically
deficient in this gene possess few PPs (12). RT-PCR anal-
yses revealed that both chemokine receptors are expressed
in CD41CD32IL-7Ra1 cells sorted from the intestine
(Fig. 1 B). Moreover, in vitro chemotactic analyses showed
that their ligands, BLC, ELC, and SLC, all induced migra-
tion of CD41CD32IL-7Ra1 cells (Fig. 1 C). Further-
more, the magnitude of response of CD41CD32IL-7Ra1
cells to BLC was comparable to that observed for B lym-
phocytes (Fig. 1 D). It was likely that the overall higher fre-
quency in CD41CD32IL-7Ra1 cells than in B cells re-
flected a high basal motility in CD41CD32IL-7Ra1 cells.
Similar results were obtained with CD41CD32IL-7Ra1
cells from E15.5 intestines. These data show that PP induc-
ers are highly competent to respond to chemokines.
Figure 1. Chemotactic activity of BLC, ELC, and SLC on
CD41CD32IL-7Ra1 cells. (A) Whole-mount immunostaining analysis
of E15.5, E16.5, and E17.5 gut with anti-CD4 mAb. (B) RT-PCR anal-
ysis on CXCR5 and CCR7 in FACS®-sorted CD41CD32IL-7Ra1 cells
from intestine at E17.5. The numbers of cells subjected to RT-PCR are
1,000, 200, 40, and 8 cells from left to right in each panel. Specific prim-
ers for CD4, IL-7Ra, and CD3-e were used as positive and negative
controls. (C) CD41 cells were prepared with Dynabeads and placed in the
chemotaxis chamber in duplicates. ELC and SLC maximally attracted
CD41 cells at 100–300 ng/ml. Results are expressed as the percentage of
input cells migrating to the lower chamber containing BLC (1 mg/ml),
ELC (300 ng/ml), or SLC (300 ng/ml). Data from individual wells are
shown as filled diamonds and means as bars. The results are representative
of three independent experiments. (D) Chemotactic response to BLC by
CD41 cells from intestine at E17.5 (filled circles) or B cells from Spl
(open squares). Lines represent the averages of duplicated Transwells. The
results are representative of at least three independent experiments.
Figure 2. Expression of BLC, ELC, VCAM-1, and ICAM-1 in PP an-
lagen. Whole-mount in situ hybridization analysis of BLC (A) and ELC
(B) expression in E17.5 intestines. Whole-mount immunostaining analy-
sis of E16.5 (C and D) and E17.5 (E and F) gut with mAbs against
VCAM-1 (C and E) and ICAM-1 (D and F). Cryostat sections of intes-
tines at E17.5 were double labeled with Abs against VCAM-1 (Alexa™
594; red) in combination with (G) anti–ICAM-1 (FITC; green) or (H)
anti-CD4 (FITC; green) (original magnification: 3200) and subjected to
confocal microscopic analysis. The insets are included to show the mor-
phology of the V1I1 cells and CD41 cells (original magnification: 3630).625 Honda et al.
To investigate the involvement of these chemokines in
the clustering of PP inducers, their expression in the em-
bryonic intestine was analyzed by whole-mount in situ hy-
bridization. ELC and BLC were both expressed in devel-
oping PPs at E17.5 (Fig. 2, A and B), but not at E15.5 (data
not shown), supporting their involvement in PP inducer
accumulation.
Isolation of V1I1 Cells. We next tried to identify the
cell population that expresses chemokines. At E16.5, when
CD41 clusters first appear, expression of ICAM-1 and
VCAM-1 are detectable among the nonlymphoid elements
of the PP anlagen (Fig. 2, C and D). Marked increase in
expression levels of VCAM-1 and ICAM-1 by E17.5 coin-
cide perfectly with an increase in the number of recruited
CD41 cells (Fig. 1 A, and Fig. 2, E and F). Confocal mi-
croscopic analysis revealed the presence of cells coexpress-
ing VCAM-1 and ICAM-1 in the PP anlagen, although
single-positive cells could also be detected (Fig. 2 G). Al-
though none of the VCAM-11 cells coexpress CD4, they
are located within close vicinity of the CD41 cells (Fig. 2
H). This led us to predict that these V1I1 cells are the
chemokine-expressing cells observed by whole-mount in
situ hybridization.
To examine this possibility, we attempted to develop a
method to isolate the V1I1 cells in the PP anlagen in order
to measure their chemokine expression. Enzymatic treat-
ment of the intact gut as described in Materials and Meth-
ods was found to result in efficient dissociation of the cells
without affecting the ability to detect VCAM-1/ICAM-1.
As shown in Fig. 3, A and B, a V1I1 population appears at
E16.5 to E17.5, consistent with the results of immunohis-
tochemical staining of whole-mount intestines. The V1I1
population comprises only z0.5% of dissociated cells from
the entire embryonic intestines. As this fraction could not
be detected in cells from embryonic intestines in IL-7Ra2/2
(Fig. 3, C and D), LTa2/2, or Id22/2 (data not shown)
mice lacking PPs (3, 8, 23), this V1I1 population should
represent cells existing in developing PPs.
Expression of ELC and BLC by V1I1 Population. Using
highly purified V1I1 populations (5 3 103 cells), we ana-
lyzed expression of BLC and ELC by RT-PCR. Other
populations from E17.5 embryonic intestines were also in-
vestigated. The purity of corresponding populations in
each sorted preparation was .98% (data not shown). As
can be seen in Fig. 3 E, V1I1 cells expressed both BLC and
ELC mRNA. Of note is that ELC was detected only in the
V1I1 population, suggesting that V1I1 cells may form spe-
cific foci to attract cells that are competent to respond to
ELC. Although BLC expression was observed in VCAM-1
single-positive cells in addition to V1I1 cells, our histologi-
cal analysis demonstrated that BLC-producing cells were
concentrated in PP anlage (Fig. 2 A). Taken together,
V1I1 cells in the PP anlagen likely form focal regions rich
in the chemokines capable of recruiting PP inducer cells.
Molecular Requirements for Induction of V1I1 Cells. We
next investigated whether formation of V1I1 cells in the
gut requires LT and IL-7Ra signals. Pregnant mice were
given a single injection of either blocking mAb to IL-7Ra
(A7R34; reference 26), LTbR-Ig, or TNFRp55-Ig at day
15.5 of gestation and cells from the intestines of embryos at
E17.5 were analyzed for VCAM-1 and ICAM-1 expres-
sion by flow cytometry. Control mice were treated with
equal amounts of human-IgG Fc fragment or polyclonal rat
IgG. As expected, after in utero treatment with A7R34 or
LTbR-Ig, depletion of the V1I1 population was observed,
whereas the corresponding population from control mice
remained unaffected (Fig. 4 A). Concurrent with the de-
pletion of this population, PP development was completely
blocked. Therefore, both IL-7Ra and LTbR signaling are
indispensable for the formation of V1I1 cells. mAb staining
and RT-PCR analysis showed that these cells indeed ex-
press LTbR (Fig. 4 B, and data not shown). On the other
hand, TNFRp55-Ig failed to block PP development (data
not shown), though this treatment consistently suppressed
the proportion of V1I1 cells. The same results were ob-
tained by treatment with higher (twofold) amounts of
TNFRp55-Ig (data not shown). Such a partial effect of
TNFRp55-Ig on PP organogenesis was consistent with
previous results on TNFRp55-deficient mice (6).
We have previously reported that PP inducers are an es-
sential source of LTa/b  for PP development, and sug-
gested the role of IL-7Ra signal for its induction. Indeed,
exposure of pregnant mice to A7R34 at E15.5 suppressed
Figure 3. Chemokine expression by
V1I1 cells. FACS® analysis of the intes-
tinal cells from at E15.5 (A) and at
E17.5 (B–D) with anti–VCAM-1 and
anti–ICAM-1. V1I1 cells are absent in
IL-7Ra2/2 embryonic intestine (D)
but present in the heterozygous litter-
mate (C). The numbers indicate the
percentage of the V1I1 population. (E)
RT-PCR analysis of transcripts encoding ELC and BLC in FACS®-
sorted V1I1 population (a) and other populations (b to d) from E17.5, as
indicated in B. Reverse-transcribed mRNA from Spl tissue was ana-
lyzed as positive control. PCR with GAPDH primers is shown as con-
trol for the cDNA content of individual samples. Similar results were
obtained from three independent experiments.626 Hematopoietic/Mesenchymal Interaction in the Peyer’s Patch Organogenesis
LT expression in CD41 cells of the PP anlage (Fig. 5, A
and D). To test whether IL-7 directly induces LTa/b ex-
pression, CD41 cells sorted from embryonic intestines
were incubated in vitro with rIL-7. This stimulation with
rIL-7 resulted in induction of LTa/b in a dose-dependent
manner (Fig. 5 B). The induction was inhibited by prein-
cubation of the cells with A7R34 (Fig. 5 C). It thus appears
likely that V1I1 cells are induced by LTa/b on the surface
of PP inducers that are expressed in response to IL-7Ra
signals.
Cellular Interactions Required for Chemokine Expression.
In concert with the failure of V1I1 cell formation in PP
anlagen, a notable defect in accumulation of CD41 cells
was observed in A7R34-treated intestines (Fig. 5 E). Under
these conditions, the distribution of CD41 cells in the gut
at E17.5 resembled that observed at E15.5, although the
number of CD41CD32 cells in the intestine measurable by
FACS® was comparable to that in the control intestine
(Fig. 5 F). Treatment with A7R34 was found not to affect
directly the migratory response of CD41 cells to BLC and
ELC (Fig. 5 G). These results suggested that the signaling
pathway from IL-7R to LTa/b is required for the expres-
sion of BLC and ELC in V1I1 cells. A recent study on
splenic follicle formation also showed that LTa/b signals
upstream of BLC and ELC (16). We measured the RNA
levels of BLC and ELC in A7R34- or control rat IgG–
treated embryonic intestines by Northern blot analysis and
whole-mount in situ hybridization. Pregnant mice were
given intravenous injections of A7R34 at E15.5 and intes-
tines were collected at E17.5. Compared with mice that re-
ceived control rat IgG, ELC message was not detected in
the intestines of A7R34-treated embryos (Fig. 6 A). Al-
though BLC expression was detectable in the A7R34-
treated embryos, its expression level was also reduced
markedly by this treatment. Likewise, ELC and BLC in the
PP anlage were not observed by in situ hybridization in in-
testines of A7R34-treated embryos (Fig. 6 B). These results
strongly suggest that LTa/b production by PP inducers in
response to the ligand for IL-7R is requisite for chemokine
expression by V1I1 cells.
Moreover, at E17.5 when chemokine producing regions
have already formed, treatment with A7R34 still inhibited
the expression of ELC and BLC, as measured by in situ hy-
bridization (data not shown). This result indicates that IL-
7R/LTa/b signaling is also required for the maintenance
of chemokine expression in the PP anlage.
Evidence for Mesenchymal Origin of V1I1 Cells. Recent
studies have shown that stromal cells, dendritic cells, and
endothelial cells are sources of chemokines (30, 31). To de-
Figure 4. Signaling through IL-7Ra and LTbR are required for in-
duction of V1I1 cells. (A) Either A7R34 (3 mg), LTbR-Ig (250 mg), or
TNFp55-Ig (250 mg) was injected (inj.) to pregnant mice at E15.5, and
cells were prepared from embryonic intestines at E17.5 and analyzed by
FACS®. Control mice were treated with equal amounts of human-IgG
Fc fragment or polyclonal rat IgG. The numbers indicate the percentage
of the cell population positive for both VCAM-1 and ICAM-1. (B) Ex-
pression of LTbR in gated V1I1 cells was measured by flow cytometry.
Cells were incubated with or without labeled anti-LTbR mAb (AFH6).
To confirm signal specificity, blocking with unlabeled AFH6 was per-
formed (right).
Figure 5. IL-7 induces LTa/b upregulation in PP inducers. (A–C)
Histograms show LTbR-Ig staining in CD41 cells. (A) CD41 cells from
E17.5 intestine after in utero treatment with A7R34 or control rat IgG at
E15.5 were analyzed. inj., injected. (B) CD41 cells from E15.5 intestine
were analyzed after in vitro cultures in the absence or presence of rIL-7 at
indicated amounts for 6 h. (C) Cells were preincubated with 3 mg/ml
A7R34 or equal amounts of polyclonal rat IgG and then incubated with
rIL-7 (40 U/ml) for 6 h. (D–G) E17.5 intestines after in utero treatment
with either A7R34 or control rat IgG at E15.5 were analyzed. (D)
Whole-mount in situ hybridization analysis of LTb expression. Arrows
indicate positive spots. (E) Whole-mount immunostaining with anti-CD4
mAb. Arrows indicate accumulation of CD41 cells. (F) The number of
CD41CD32 cells in the intestine was measured by FACS®. (G) Chemo-
tactic response of CD41 cells from intestines after treatment with either
control rat IgG (white bars) or A7R34 (black bars) to BLC or ELC.627 Honda et al.
termine the lineage derivation of V1I1 cells, we checked
for expression of various cell surface markers. Flow cytom-
etry analyses showed that V1I1 cells were negative for
CD45 (a marker for hematopoietic cells), CD11c (a marker
for dendritic cell), and VE-cadherin (a marker for vascular
endothelial cells) expression, whereas they expressed both
PDGFRa and PDGFRb (Fig. 7 A, and Table I). Although
PDGFRa and PDGFRb are singly expressed in a variety
of cell lineages (32, 33, 34), coincident expression of both
rarely occurs in nonmesenchymal lineages, suggesting a
mesenchymal origin for V1I1 cells.
To determine if indeed this is the case, we prepared
V1I1 cells as single cell suspensions and analyzed them by
electron microscopy along with other fractions (population
c and d in Fig. 3 B) obtained from the gut at E17.5 (Fig. 7
B). Pale euchromatic nuclei and relatively rich cytoplasm
were common features of the population a (V1I1 cells) and
d cells. Compared with fewer cytoplasmic component in
population d cells, however, V1I1 cells had well-developed
endoplasmic reticulum (arrowheads), many vacuoles, and
occasional lipid droplets (arrows). These morphologic fea-
tures suggested high secretory activity and resembled cells
from lymphoid organ environments such as thymic mesen-
chymal cells (35) or bone marrow reticular cells (36). In
contrast, population c cells showed many cytoplasmic pro-
jections that are characteristic to dendritic cells. About 60%
Figure 6. Signal pathway from IL-7R to LTa/b regulates
expression of BLC and ELC. (A) Northern blot analysis of
BLC and ELC mRNA from E17.5 intestines after treatment
with either A7R34 or polyclonal rat IgG at E15.5. GAPDH
was used as control to quantitate amount of RNA loaded. To-
tal RNA isolated from Spl tissue was loaded as positive con-
trol. inj., injected. (B) Whole-mount in situ hybridization
analysis of BLC and ELC expression in E17.5 intestines after
treatment with A7R34 or control rat IgG at E15.5. Several
spots (arrows) positive for expression of BLC and ELC are vi-
sualized in the control intestine.
Figure 7. V1I1 cells are of a mesenchymal lineage. (A) Three-color
FACS® analysis of various cell surface molecules (CD45, CD11c, VE-
cadherin, PDGFRa, PDGFRb, and MAdCAM-1; filled histograms) or
isotype-matched mAbs (open histograms) on gated V1I1 cells. (B) Rep-
resentative transmission electron microscopic appearance of cells in the
populations indicated in Fig. 3 B obtained from the gut at E17.5. FACS®-
sorted cells were fixed and embedded for sectioning. Arrowheads and ar-
rows indicate well-developed endoplasmic reticulum and lipid droplets,
respectively.
Table I. Phenotypic Characterization of V1I1 Cell
Surface antigen Expression
CD45 2
CD11c 2
CD11b 2
B220 2
CD3 2
CD4 2
CD40 1
IL-7Ra2
VE-cadherin 2
Flk-1 2
PECAM-1 2
VCAM-1 High
ICAM-1 High
MAdCAM-1 High
PDGFRa1
PDGFRb1
BP-3 2
FDC-M1 2
CD35 2
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of population c cells actually express CD11c (data not
shown).
Taken together, we concluded that V1I1 cells were
likely from the mesenchymal lineage. Mutual interaction
between the hematopoietic PP inducer and the mesenchy-
mal V1I1 cells appears to form the major framework of cel-
lular interaction involved in PP anlagen formation.
Discussion
Histological events that characterize the initial phase of
PP organogenesis are the appearance of segregated regions
expressing VCAM-1 and ICAM-1 and concomitant accu-
mulation of various hematopoietic cells. Among the he-
matopoietic lineages that appear in the PP anlage, IL-
7Ra1CD32 cells are likely to be the most important for
PP formation, as only this population expresses the LTa/b
requisite for PP organogenesis (10). However, little is
known about how these cells congregate in the PP anlage,
although a variety of chemokines have been implicated in
the accumulation of hematopoietic cells. Recently, Mebius
et al. demonstrated that CD41CD32 cells in the embryonic
mesentery express CXCR5 (24). Here we elucidate the
molecular mechanisms regulating cell–cell interaction re-
quired for PP organogenesis, with particular emphasis on
the involvement of chemokines.
Consistent with previous reports, CD41CD32IL-7Ra1
cells sorted from the embryonic gut were found to express
the BLC receptor, CXCR5. Moreover, we found that
CCR7, the receptor for ELC and SLC, is also expressed by
this population. Thus, PP inducers express the receptors for
homeostatic chemokines and we confirmed that both re-
ceptors are functional by in vitro migration assays. Surpris-
ingly, in response to BLC, PP inducers demonstrated a
comparable level of chemotactic activity to that of B cells,
which have been considered the specific target of BLC
(30). In situ hybridization analyses revealed that ELC and
BLC expression become detectable concurrently in PP an-
lagen. Taken together, it is highly likely that these two
chemokines play a role in the clustering of PP inducers.
Previous studies showed that null mutations of BLC or
CXCR5 result in reduction of the number of PPs in addi-
tion to defects in organized peripheral lymphoid tissue for-
mation (11, 12). This strongly supports involvement of
BLC/CXCR5 in PP induction, but the partial phenotype
suggests that CCR7 might compensate this defect to some
extent. Despite the specific localization of ELC expression
in PP anlagen, CCR7 null mice develop normal numbers
of PPs (37), indicating that BLC is likely the major
chemokine regulating migration of the PP inducer.
If BLC and ELC are the molecules responsible for accu-
mulation of PP inducers, a possible scenario is that
chemokine-producing regions are established before the
involvement of PP inducers. Thus, the IL-7Ra–dependent
process of PP induction would occur after accumulation of
PP inducers in the preestablished PP anlage. However, we
showed here that production of chemokines as well as
VCAM-1/ICAM-I expression are dependent on IL-7Ra–
induced production of LTa/b by PP inducers. This indi-
cates that chemokine expression, which we believe requi-
site for the migration of PP inducers, are in turn induced
by PP inducers themselves. Moreover, although chemo-
kine producing regions have already formed at E17.5,
maintenance of this region appears dependent on LTa/b
stimulation. Hence, it is likely that PP inducers are the cells
which act on surrounding tissues to induce chemokines,
and IL-7Ra and LTa/b are molecules involved in up-
stream regulation of chemokine production in the PP an-
lagen.
We investigated whether or not V1I1 cells are the pro-
ducers of ELC and BLC. For this purpose, we established
conditions to allow dissociation of V1I1 cells from embry-
onic intestines and performed flow cytometry analysis
which enabled us to address the following points. First,
V1I1 cells express LTbR and thus could be the target of
PP inducers. Furthermore, they produce ELC and BLC.
Although VCAM-1 single-positive cells also express low
levels of BLC, V1I1 cells appear to be the sole population
expressing ELC. Third, multicolor analysis of this popula-
tion revealed expression of both PDGFRa and PDGFRb,
but no hematopoietic or endothelial markers, a feature that
is rarely found except among mesenchymal lineages. Mor-
phological analysis of purified V1I1 cells indicated that they
shared the characteristics of stromal cell components sup-
porting lymphoid organs such as thymic (35) and bone
marrow reticular cells (36). Taken together, these observa-
tions support that V1I1 cells belong to the mesenchymal
lineage and are activated by PP inducers to express
VCAM-1, ICAM-1, ELC, and BLC; conversely all of
these molecules have the potential to attract PP inducers
and other hematopoietic cell lineages to the PP anlage.
Thus, in the sense that V1I1 cells are an active component
of PP organogenesis rather than a passive target of the PP
inducer, our terminology “PP organizer” appears appropri-
ate (21, 22).
Interestingly, V1I1 cells express MAdCAM-1 and
CD40, two molecules that are rarely observed in the mes-
enchymal lineage. We speculate that expression of these
molecules may reflect representation by V1I1 of an acti-
vated state of mesenchymal cells. Another active mesen-
chymal like cell is the follicular dendritic cell (FDC) for
which extensive, but to date yet inconclusive, attempts
have been undertaken to identify its derivation. All of the
above molecules have been reported to be expressed in
FDCs, thus suggesting a relationship between V1I1 cells
and FDCs. However, other FDC-specific markers such as
FDC-M1 or CD35 could not be detected in V1I1 cells. In
any case, determination of the lineage derivation of FDCs
remains an important issue.
A striking feature of PP inducers and organizers is the
extent to which they are mutually complementary. PP in-
ducers express LTa/b to activate PP organizer, while PP
organizers express chemokines to activate PP inducers.
This interdependent relationship in which both compo-
nents are at the same time activator and responder raises a
question that remains still unanswerable; namely, what is629 Honda et al.
the initial event for PP induction? The answer to this ques-
tion might also explain how the position of PP anlagen is
determined. In an earlier review, we presented a model
that the first event for PP induction is the activation of PP
inducers by the ligand for IL-7Ra, which should be ex-
pressed by cells distinct from either PP inducer or organiz-
ers (22). If this is the case, we need to identify which cells
express the IL-7Ra ligand and how expression of this
ligand is induced in the specific region from which PP an-
lagen develop. However, our extensive attempts to pin-
point expression of IL-7 and thymic stroma–derived lym-
phopoietin (TSLP) in the embryonic intestine have so far
failed. In any case, the above model requires involvement
of two cellular components to trigger the first event, with
subsequent inducer/organizer interaction.
An attractive explanation for this process involving
only two cellular compartments is the “reaction-diffusion
model” (38), proposing that PP position is determined not
entirely by program but by interaction between two diffus-
ible factors, one of which is essential for initiating the de-
velopmental process. Such a mechanism has been impli-
cated in various situations such as stripe formation in fish
(39), and more recently, determination of hair follicle an-
lagen (40). This model, though simpler, is difficult to
prove.
Whatever the mechanisms underlying the triggering
process, we think that interaction between PP inducer and
PP organizer starts in a few cells, but the segregated PP an-
lagen become detectable rapidly within 24 h. This process
is reminiscent to the process of delayed-type hypersensitiv-
ity (DTH) reaction in the skin, in which antigen-specific T
cells enter in the antigen injected site and recruit many
other cells within 24 h. Indeed, previous studies demon-
strated that even a single antigen-reactive T cell can induce
this response (41). Likewise, once a small interaction unit
with PP inducer and PP organizer are stimulated, it rapidly
spreads to a large region by recruiting more and more in-
ducers in the region. Such a similarity suggests that the in-
flammatory process may be a prototype from which the
mechanisms underlying PP organogenesis are derived.
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